+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme a:cholesterol acyltransferase 2 have opposite atherosclerotic potential



Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme a:cholesterol acyltransferase 2 have opposite atherosclerotic potential



Circulation Research 95(10): 998-1004



Evidence suggests that ACAT2 is a proatherogenic enzyme that contributes cholesteryl esters (CEs) to apoB-containing lipoproteins, whereas LCAT is an antiatherogenic enzyme that facilitates reverse cholesterol transport by esterifying free cholesterol on HDL particles. We hypothesized that deletion of LCAT and ACAT2 would lead to absence of plasma CEs and reduced atherosclerosis. To test this hypothesis, ACAT2-/- LCAT-/- LDLr-/-, ACAT2-/- LDLr-/-, and LCAT-/- LDLr-/- mice were fed a 0.15% cholesterol diet for 20 weeks. In comparison to LDLr-/- mice, the total plasma cholesterol (TPC) of ACAT2-/- LCAT-/- LDLr-/- mice was 67% lower because of the complete absence of plasma CEs, leading to 94% less CE accumulation in the aorta. In the LCAT-/- LDLr-/- mice, TPC and atherosclerosis were significantly higher because of increased accumulations of ACAT2-derived CE. In ACAT2-/- LDLr-/- mice, again compared with LDLr-/- mice, TPC was 19% lower, whereas atherosclerosis was 88% lower. Therefore, the absence of ACAT2 led to a significant reduction in TPC although benefits in reduction of atherosclerosis were much more pronounced. Overall, the data suggest that ACAT2-derived CE is the predominant atherogenic lipid in blood, and that an important goal for prevention of atherosclerosis is to limit ACAT2-derived CE accumulation in lipoproteins.

(PDF emailed within 0-6 h: $19.90)

Accession: 049935471

Download citation: RISBibTeXText

PMID: 15486318

DOI: 10.1161/01.RES.0000147558.15554.67


Related references

Cholesterol esterifying enzymes lecithin cholesterol acyltransferase lcat and acyl coenzyme a cholesterol acyltransferase acat. Converse, C A And E R Skinner (Ed ) Practical Approach Series: Lipoprotein Analysis Xx+251p Irl Press at Oxford University Press: Oxford, England, Uk; New York, New York, Usa Illus 187-201, 1992

Acyl-coenzyme A:cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1, and low-denisty lipoprotein receptor deficiencies in nephrotic syndrome. Circulation 110(4): 419-425, 2004

Acyl-coenzyme A: Cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1, and low-denisty lipoprotein receptor deficiencies in nephrotic syndrome. Circulation 110(4): 419-425, July 27, 2004

A comparison of the esterification of steroids by rat lecithin:cholesterol acyltransferase and acyl coenzyme A:cholesterol acyltransferase. Endocrinology 136(1): 180-186, 1995

The submicrosomal localization of acyl-coenzyme A-cholesterol acyltransferase and its substrate, and of cholesteryl esters in rat liver. Biochemical Journal 174(3): 863-872, 1978

Compared with Acyl-CoA:cholesterol O-acyltransferase (ACAT) 1 and lecithin:cholesterol acyltransferase, ACAT2 displays the greatest capacity to differentiate cholesterol from sitosterol. Journal of Biological Chemistry 278(48): 47594-47601, 2003

Two different allelic mutations in the lecithin-cholesterol acyltransferase gene associated with the fish eye syndrome. Lecithin-cholesterol acyltransferase (Thr123----Ile) and lecithin-cholesterol acyltransferase (Thr347----Met). Journal of Clinical Investigation 89(2): 499-506, 1992

Increased expression of acyl-coenzyme A: cholesterol acyltransferase-1 and elevated cholesteryl esters in the hippocampus after excitotoxic injury. Neuroscience 185: 125-134, 2011

ABO blood groups, serum cholesteryl esters and plasma lecithin: cholesterol acyltransferase activity. Clinical Genetics 3(3): 183-187, 1972

Low density lipoprotein-activated lysolecithin acylation by human plasma lecithin-cholesterol acyltransferase. Identity of lysolecithin acyltransferase and lecithin-cholesterol acyltransferase. Journal of Biological Chemistry 255(19): 9275-9280, 1980

Alpha-lecithin:cholesterol acyltransferase deficiency. Lack of both phospholipase A2 and acyltransferase activities characteristic of high density lipoprotein lecithin:cholesterol acyltransferase in fish eye disease. Acta Medica Scandinavica 222(1): 23-26, 1987

α-Lecithin: Cholesterol Acyltransferase Deficiency : Lack of Both Phospholipase A2 and Acyltransferase Activities Characteristic of High Density Lipoprotein Lecithin: Cholesterol Acyltransferase in Fish Eye Disease. Journal of Internal Medicine 222(1): 23-26, 1987

Molecular species of cholesteryl esters formed via plasma lecithin:Cholesterol acyltransferase in fish oil supplemented dogs. Nutrition Research 17(5): 861-872, 1997

Incorporation of lipoxygenase products into cholesteryl esters by acyl-CoA:cholesterol acyltransferase in cholesterol-rich macrophages. Biochemical Journal 256(3): 807-814, 1988

Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: effects of incubation with lecithin: cholesterol acyltransferase in vitro. Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum 142: 31-55, 1975